0.87
-0.0318(-3.51%)
Currency In USD
| Previous Close | 0.91 |
| Open | 0.89 |
| Day High | 0.91 |
| Day Low | 0.87 |
| 52-Week High | 23.77 |
| 52-Week Low | 0.69 |
| Volume | 41,775 |
| Average Volume | 2.83M |
| Market Cap | 11.47M |
| PE | 1.32 |
| EPS | 0.66 |
| Moving Average 50 Days | 1.05 |
| Moving Average 200 Days | 4.8 |
| Change | -0.03 |
SCIENTURE Announces Executive Leadership Transition
GlobeNewswire Inc.
May 22, 2025 12:05 PM GMT
TAMPA, FL, May 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and careg
SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.
GlobeNewswire Inc.
May 19, 2025 12:05 PM GMT
TAMPA, FL, May 19, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through dev
SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
GlobeNewswire Inc.
Apr 22, 2025 12:05 PM GMT
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through d